Wellbutrin is a psychiatric medication. It belongs to a class of drugs called aminoketone antidepressants, and the FDA has approved it for two psychiatric conditions: major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD). The same active ingredient, bupropion, is also sold under the brand name Zyban for smoking cessation, which is not a psychiatric use but relies on the same brain chemistry.
How Wellbutrin Works in the Brain
Wellbutrin stands apart from the most commonly prescribed antidepressants because it doesn’t target serotonin. Most antidepressants, including the well-known SSRIs like sertraline (Zoloft) and fluoxetine (Prozac), work primarily by increasing serotonin levels. Wellbutrin instead blocks the reabsorption of two different brain chemicals: dopamine and norepinephrine. This makes more of both available in the brain, which is thought to improve mood, energy, and concentration.
The drug is also unusual because your body converts it into several active byproducts that are actually more potent than the original compound. These byproducts are a major reason the medication keeps working throughout the day, even though the parent drug clears relatively quickly, with a half-life of about 12 hours.
FDA-Approved Psychiatric Uses
Wellbutrin has two official psychiatric indications. The first and most common is major depressive disorder, the condition most people think of as clinical depression. The second is seasonal affective disorder, where it’s used preventively to keep depressive episodes from developing during fall and winter months. It’s typically started before symptoms begin and continued through the season.
Off-Label Use for ADHD
Because Wellbutrin increases dopamine availability, some clinicians prescribe it off-label for attention deficit hyperactivity disorder in adults. A controlled trial published in the American Journal of Psychiatry found that adults taking bupropion experienced a 42% reduction in ADHD symptoms after six weeks, compared to 24% for those on placebo. By another measure, 76% of people on bupropion met the threshold for meaningful improvement, versus 37% on placebo. It’s not a first-line ADHD treatment, but it can be a reasonable option when stimulant medications aren’t appropriate or cause too many side effects.
The Smoking Cessation Connection
The same drug is marketed as Zyban for helping people quit smoking, which is technically a non-psychiatric use. In a clinical trial comparing several approaches, bupropion alone produced a 46% quit rate after 10 weeks of treatment. That outperformed both the nicotine patch alone (32%) and placebo (20%). Combining bupropion with a nicotine patch pushed the rate slightly higher to 51%. If you’re prescribed Zyban, you’re taking the same molecule as Wellbutrin, which matters because the two should never be taken together.
Side Effects Worth Knowing About
Wellbutrin’s side effect profile is noticeably different from SSRIs, and for many people, that difference is the main reason it’s chosen. SSRIs are well known for causing sexual side effects like reduced desire and difficulty with orgasm. The Mayo Clinic lists bupropion among the antidepressants with the lowest rates of sexual dysfunction, while SSRIs like paroxetine (Paxil) carry the highest risk. For people who’ve experienced sexual side effects on other antidepressants, this distinction is often the deciding factor.
Common side effects include insomnia (reported by about 38% of participants in one trial), headache, dry mouth, and gastrointestinal discomfort. Many of these ease after the first few weeks.
The most serious concern is seizure risk. At doses up to 300 mg per day of the sustained-release form, the risk is roughly 1 in 1,000. With the immediate-release form at higher doses (300 to 450 mg per day), that rises to about 4 in 1,000. Going above 450 mg per day increases the risk almost tenfold, which is why there’s a strict daily ceiling. People with a history of seizures, eating disorders, or heavy alcohol use face higher risk and are generally not good candidates for this medication.
The Boxed Warning on Suicidality
Like all antidepressants, Wellbutrin carries the FDA’s most prominent safety warning regarding suicidal thoughts and behavior. This risk is specifically elevated in children, adolescents, and young adults under 25 during the early weeks of treatment or after dose changes. In adults over 24, clinical trials did not show this increased risk compared to placebo. In adults 65 and older, antidepressants actually showed a reduction in suicidality risk. The warning applies to the medication class broadly, not to bupropion uniquely.
Available Formulations
Wellbutrin comes in three release profiles, each designed to be taken on a different schedule. The immediate-release version peaks in about 2 hours and is taken two or three times daily. The sustained-release (SR) version peaks in about 3 hours and is usually taken twice daily. The extended-release (XL) version peaks around 5 hours and is taken once a day. The XL formulation is the most widely prescribed because of its convenience, and it’s the version approved for seasonal affective disorder prevention. All three contain the same active ingredient and produce the same active byproducts in the body, so the choice comes down to dosing preference and what your insurance covers.